Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Parkinson’s disease is treated by l-dopa with a decarboxylase inhibitor, dopamine agonists and monoamine oxidase (MAO) or catechol-O-methyl transferase (COMT) inhibitors. The high frequency stimulation of the subthalamic nucleus is a nonpharmacological method to improve motor symptoms in Parkinsonian patients.....Read more
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi